Negotiations between New York state lawyers, some social equity applicants and a group of multistate operators to settle two related lawsuits over marijuana retail licensing have ended without a compromise.
Medical marijuana company Cann Pharmaceutical, also known as Better, filed a countersuit against InterCure and its management team seeking $35 million in damages.
The once-high-flying co-founders of MedMen Enterprises, Adam Bierman and Andrew Modlin, are back in the spotlight – this time for a new court battle. Or two.
A legal and financial liability has emerged over the past two years threatening the coffers of marijuana businesses: class action lawsuits filed by recipients of unwanted text-message advertisements who allege they’re getting spammed with deals and sales.
Five Arkansas companies with permits to grow medical cannabis are suing to stop three more cultivation licenses from being issued.
After filing suit against MedMen in January alleging serious mismanagement and a breach of fiduciary duty – and asking a court for nearly $220 million in damages – two early investors in the California marijuana company announced this week they’ve withdrawn their lawsuit and are seeking arbitration.
